InvestSMART

Global Health Limited (ASX:GLH)

ALERT: Price-sensitive ASX Announcement for GLH
Current share price for GLH : $0.065 -0.035 (-35%)+
Release
28 Oct 2025 9:04AM
Price at Release
$0.100
Full Release
download
Summary
Global Health Limited's Appendix 4C for the quarter ending 30 September 2025 details the company's financial activities and cash flow. The company reported receipts from customers totaling $2,362,000 and total operating payments of $3,387,000, resulting in a net cash outflow from operating activities of $1,065,000 for the quarter. The company's cash balance at the end of the quarter was $439,000, with a noted delay in receiving a $720,000 R&D refund which impacted cash levels. There were no significant investing activities, while financing activities yielded a net cash inflow of $137,000. The report also highlights future strategies, including leveraging AI for efficiency, and outlines the company's financial facilities and obligations. Payments to related parties for the quarter amounted to $91,000, primarily for directors' remuneration.
Key Points
  • Receipts from customers: $2,362,000
  • Net cash outflow from operations: $1,065,000
  • End of quarter cash balance: $439,000
  • Delayed R&D refund affecting cash flow
  • No significant investing activities
  • Net inflow from financing activities: $137,000
  • Payments to related parties: $91,000
  • AI leverage for operational efficiency
  • Future financial strategies and obligations
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.